Regenerative medicine technique brings surgeons one step closer to helping patients
A new study by researchers at Children’s Hospital Los Angeles has shown that tissue-engineered small intestine grown from human cells replicates key aspects of a functioning human intestine. The tissue-engineered small intestine they developed contains important elements of the mucosal lining and support structures, including the ability to absorb sugars, and even tiny or ultra-structural components like cellular connections.
Published online January 8 by the American Journal of Physiology: GI & Liver, the work brings surgeons one step closer to helping human patients using this regenerative medicine technique.
Tissue-engineered small intestine (TESI) grows from stem cells contained in the intestine and offers a promising treatment for short bowel syndrome (SBS), a major cause of intestinal failure, particularly in premature babies and newborns with congenital intestinal anomalies. TESI may one day offer a therapeutic alternative to the current standard treatment, which is intestinal transplantation, and could potentially solve its largest challenges – donor shortage and the need for lifelong immunosuppression.
Tracy C. Grikscheit, MD, a principal investigator in The Saban Research Institute of CHLA and its Developmental Biology and Regenerative Medicine program, is also a pediatric surgeon at Children’s Hospital Los Angeles and an assistant professor of surgery at the Keck School of Medicine of the University of Southern California.
Grikscheit aims to help her most vulnerable young patients, including babies who are born prematurely and develop a devastating disease called necrotizing enterocolitis (NEC), where life-threatening intestinal damage requires removal of large portions of the small intestine. Without enough intestinal length, the babies are dependent on intravenous feeding, which is costly and may cause liver damage. NEC and other contributors to intestinal failure occur in 24.5 out of 100,000 live births, and the incidence of SBS is increasing. Nearly a third of patients die within five years.
CHLA scientists had previously shown that TESI could be generated from human small intestine donor tissue implanted into immunocompromised mice. However, in those initial studies – published in July 2011 in the biomedical journal Tissue Engineering, Part A – only basic components of the intestine were identified. For clinical relevance, it remained necessary to more fully investigate intact components of function such as the ability to form a healthy barrier while still absorbing nutrition or specific mechanisms of electrolyte exchange.
The new study determined that mouse TESI is highly similar to the TESI derived from human cells, and that both contain important building blocks such as the stem and progenitor cells that will continue to regenerate the intestine as a living tissue replacement. And these cells are found within the engineered tissue in specific locations and in close proximity to other specialized cells that are known to be necessary in healthy human intestine for a fully functioning organ.
Read more: Researchers Grow Functional Tissue-Engineered Intestine from Human Cells
The Latest on: Regenerative medicine
via Google News
The Latest on: Regenerative medicine
- Global Regerative Medicine Markets Report 2020-2026 - Focus on Acellular Products, Cellular Products, Autologous Products, Allogeneic Productson March 1, 2021 at 4:14 pm
The "Regenerative Medicine Market Share, Size, Trends, & Industry Analysis Report, By Therapy; By Products; By Application; By Region: Segment Forecast, 2020-2026" report has been added to ...
- Regenerative Medicine Market Analysis, Trends, Scope, Regional Estimation, Company Profiles and Forecast 2020 to 2027on March 1, 2021 at 9:21 am
CANADA -The global Regenerative Medicine Market is expected to grow at a noteworthy CAGR of 16.1% from 2020 to ...
- Regenerative Medicine Market To Record A Robust Growth Rate For The COVID-19 Period During 2025on March 1, 2021 at 8:29 am
Mar 01, 2021 (AmericaNewsHour) -- As stated by the research report published by Azoth Analytics in August 2019, the Global Regenerative Medicine Market was valued at USD 22,814.45 million the year ...
- Restore hair with regenerative medicine at The Osteopathic Centeron February 26, 2021 at 1:19 pm
We’re joined by Dr. Sean Goddard and Dr. Lowell McCauley from The Osteopathic Center to talk about the restoration process using regenerative medicine. Copyright 2021 Nexstar Inc. All rights reserved.
- R3 Stem Cell Wins 2021 Most Outstanding Regenerative Medicine Company Awardon February 26, 2021 at 12:58 pm
Coming off an Award filled 2020, R3 Stem Cell has now won the Most Outstanding Regenerative Medicine Company Award for 2021.
- Global Regenerative Medicine Market Share, Size, Trends, & Industry Analysis Report 2020-2026 by Therapy; Products; Application; Regionon February 25, 2021 at 6:08 am
The "Regenerative Medicine Market Share, Size, Trends, & Industry Analysis Report, By Therapy; By Products; By Application; By Region: Segment Forecast, 2020-2026" report has been added to ...
- New platform can help treat neurodegenerative diseases through regenerative medicineon February 23, 2021 at 9:03 pm
By discovering a new printable biomaterial that can mimic properties of brain tissue, Northwestern University researchers are now closer to developing a platform capable of treating these conditions ...
- Superstructures formed by 'walking' molecules could help create neurons for regenerative medicineon February 23, 2021 at 6:18 am
Imagine if surgeons could transplant healthy neurons into patients living with neurodegenerative diseases or brain and spinal cord injuries. And imagine if they could "grow" these neurons in the ...
- Regenerative Medicine Market Worth $17.9 Billion – In Depth Analysis of Growth Dynamics and Recent Developmentson February 19, 2021 at 11:35 am
The global regenerative medicine market is expected to reach $17.9 billion by 2025. Regenerative medicine products market report provides crucial industry insights that will help your business grow ...
- Bile duct organoids could be used as cell therapy for regenerative medicineon February 19, 2021 at 4:50 am
For the first time, scientists have grown bile duct organoids that could repair damaged ducts and livers as a new cell therapy.
via Bing News